IC is characterized by bladder pressure, bladder pain, urinary urgency, and urinary frequency. In severe cases, patients may need to urinate up to 60 times per day. Most IC patients experience flares, times during which symptoms can worsen dramatically.
Achieving a timely diagnosis
Too often, clinicians arrive at a diagnosis of IC only by ruling out many other diseases and complications, including urinary tract infections, bladder infections, bladder stones, STDs, and other conditions that may cause similar symptoms.
Patients can also be given a self-reported Pelvic Pain and Urgency/Frequency (PUF) Questionnaire. The PUF Questionnaire can be considered a key tool in the diagnosis of IC by accurately and efficiently understanding the severity of the symptoms associated with IC ultimately to help get your patients on the road to immediate treatment.
Treatment options for IC
To date, treatment options for IC symptoms have relied heavily on behavioral changes (eg, diet modifications and self-management) and oral medications (eg, Elmiron and antidepressants) that may take months to be effective.
Bladder instillations, included in the American Urological Association (AUA) treatment guidelines for IC, provide immediate treatment because medication is delivered directly to the bladder. Click here for the full AUA guidelines.
PPS-DR compounded formulations
PPS-DR* is a compounded formulation that has been prescribed as a low cost alternative for the treatment of interstitial cystitis. The compounded formulation is carefully prepared for individually identified patients in delayed release capsules in amounts that may meet your patients’ specific needs and allows for dosing as little as twice daily for your patients. Click here for more details on PPS-DR.
Our compounded formulation provides:
- Improved patient experience
- Affordability for your patients
- Increased convenience with as little as twice daily dosing